|
Theranostics 2018
WNT6 is a novel oncogenic prognostic biomarker in human glioblastomaDOI: 10.7150/thno.25025 Keywords: biomarker, glioblastoma, oncogene, prognosis, WNT6, WNT pathway Abstract: Glioblastoma (GBM) is a universally fatal brain cancer, for which novel therapies targeting specific underlying oncogenic events are urgently needed. While the WNT pathway has been shown to be frequently activated in GBM, constituting a potential therapeutic target, the relevance of WNT6, an activator of this pathway, remains unknown.
|